← Leaderboards
Andrei Bakin
Roswell Park Cancer Institute Corp
$2,370,189
Attributed
$2,370,189
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $334K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,370,189 · 3
By mechanism
R01$1,614,201 · 1
R21$755,988 · 2
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Pawel Kalinski$15,491,276
- Christos Fountzilas$1,631,453
Others in their field
Top investigators on “Neoplasm /Cancer Invasiveness”
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Richard L Schilsky · University Of Chicago$62,990,995
- Bruce J Hillman · American College Of Radiology$58,288,467
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$22,909,759
- Philip J Disaia · University Of California Irvine$21,551,991
- Israel David Goldman · Yeshiva University$19,038,780
Research focus
Neoplasm /Cancer InvasivenessNeoplasm /Cancer TherapyNeoplastic ProcessMitogen Activated Protein KinaseLaboratory MouseMetastasisMalignant NeoplasmsMethodologyFibronectinsCellsGuanosinetriphosphatase Activating ProteinMalignant Breast NeoplasmAnimalsMediatingGreen Fluorescent ProteinsCell TransformationCell MigrationCytotoxicityBreast Cancer TreatmentBreast CarcinomaBreast NeoplasmsFibroblastsCarcinomaCell Line
Grant awards (9)
A Novel Treatment Strategy for Metastatic Breast Cancer$192,653
R21 · FY2023 · CA · contact PI
A Novel Treatment Strategy for Metastatic Breast Cancer$235,901
R21 · FY2022 · CA · contact PI
Development of inhibitors targeting the TGF-beta-NfkB axis in cancer$152,434
R21 · FY2013 · CA · contact PI
Development of inhibitors targeting the TGF-beta-NfkB axis in cancer$175,000
R21 · FY2012 · CA · contact PI
Mechanisms of TGFbeta-mediated fibroblastic transition$330,110
R01 · FY2006 · CA · contact PI
Mechanisms of TGFbeta-mediated fibroblastic transition$334,041
R01 · FY2005 · CA
Mechanisms of TGFbeta-mediated fibroblastic transition$330,144
R01 · FY2004 · CA
Mechanisms of TGFbeta-mediated fibroblastic transition$326,360
R01 · FY2003 · CA
Mechanisms of TGFbeta-mediated fibroblastic transition$293,546
R01 · FY2002 · CA